Capstone Investment Advisors’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Capstone Investment Advisors's AGN Position: Q2 2020 in Review
Capstone Investment Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 91,010 shares — an estimated $16.1M sold.
Capstone Investment Advisors first reported a position in AGN in Q2 2013 and held it in 16 quarters. The position peaked at $106M in Q3 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Capstone Investment Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Capstone Investment Advisors sold 91,010 Allergan plc shares in Q2 2020, an estimated $16.1M.
- Capstone Investment Advisors first reported a position in Allergan plc in Q2 2013 and held it in 16 quarters.
- Capstone Investment Advisors's Allergan plc position peaked at $106M in Q3 2019.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Capstone Investment Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.